DJIA 17,160.24 129.10 0.76%
NASDAQ 4,553.91 35.01 0.77%
S&P 500 2,001.59 17.46 0.88%
market minute promo

Myriad Genetics (NASDAQ: MYGN)

37.67 1.27 (3.49%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MYGN $37.67 3.49%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $36.44
Previous Close $36.40
Daily Range $36.10 - $37.93
52-Week Range $20.02 - $42.50
Market Cap $2.7B
P/E Ratio 16.18
Dividend (Yield) $0.00 (0.0%)
Volume 518,720
Average Daily Volume 846,698
Current FY EPS $1.94

Sector

Services

Industry

Diversified Services

Myriad Genetics (MYGN) Description

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products. Website: http://www.myriad.com/

News & Commentary Rss Feed

3 Stocks Even Volatility-Loving Nasdaq Investors Hate

The Nasdaq Composite may be hitting a multidecade high, but pessimists are piling into these three Nasdaq-listed stocks. Are things really as bad as these short-interest figures indicate?

Quest Diagnostics Offers A Good Long-Term Opportunity

Myriad Genetics Posts Encouraging myPath Melanoma Data - Analyst Blog

Myriad myPath Melanoma Test Reduced Indeterminate Cases By 76% And Changed Treatment In 35 % Of Case

Myriad myPath Melanoma Test Reduced Indeterminate Cases By 76% And Changed Treatment In 35 % Of Cases

Myriad Publishes myRisk Hereditary Cancer Study In Cancer

Update: Myriad Genetics' Patents Are Facing Trouble Again

FuelCell Upgrade; Amazon Announces New Product

FuelCell Upgrade; Amazon Announces New Product

Myriad Genetics' Q4 Earnings Beat Estimates, Revenues Up Y/Y - Analyst Blog

SeaWorld Drops On Downbeat Results; Canadian Solar Shares Surge

SeaWorld Drops On Downbeat Results; Canadian Solar Shares Surge

See More MYGN News...

MYGN's Top Competitors

MYGN $37.67 (3.49%)
Current stock: MYGN
AMGN $138.97 (0.72%)
Current stock: AMGN
GILD $104.11 (3.09%)
Current stock: GILD
BIIB $327.38 (2.27%)
Current stock: BIIB